Novo Nordisk Secures FDA Approval For Higher-Dose Wegovy

All NewsMarch 19, 2026

FDA approves higher-dose Wegovy to boost weight loss in adults with obesity, with rollout expected across U.S. pharmacies in April.

Importance Rank:

We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.

Cookie settings ACCEPT

Manage consent